Literature DB >> 31114715

Repeatability of Fluorescence Lifetime Imaging Ophthalmoscopy in Normal Subjects With Mydriasis.

Soonil Kwon1,2, Enrico Borrelli1, Wenying Fan1, Adel Ebraheem1, Kenneth M Marion1, SriniVas R Sadda1,3.   

Abstract

PURPOSE: We evaluate the repeatability of fluorescence lifetime imaging ophthalmoscopy (FLIO) in normal subjects with mydriasis and explore factors that influence FLIO imaging.
METHOD: Thirty-two healthy participants (63 eyes) were enrolled in this prospective study. The Heidelberg Engineering FLIO system uses a 473 nm blue laser light and the emitted fluorescence is detected in two wavelength channels, short and long spectral channels (SSC, LSC). The mean fluorescence lifetime (τm) values were computed for the entire scan area as well as in five regions of interest (ROI, 1 × 1 mm) at the fovea and superior, nasal, inferior, and temporal portions of the macula. Intraclass correlation coefficients (ICC) and coefficients of variation (CV) were used to assess the repeatability. Age, macular thickness, and vascular density also were correlated with τm.
RESULTS: The repeatability was good for both channels (ICC, 0.956∼0.995; CV, 9∼16%). The τm for the entire scan was 367.8 ± 58.1 picoseconds (ps) in SSC and 322.5 ± 34.0 ps in LSC. τm was the shortest in the fovea and significantly shorter in the temporal region compared to other regions. τm was positively correlated with age (r = 0.588 for SSC and r = 0.584 for LSC, P = 0.000) and retinal thickness (r = 0.298 for SSC and r = 0.322 for LSC, P = 0.000), and negatively correlated with vascular density (r = -0.112, P = 0.055 for SSC and r = -0.119, P = 0.040 for LSC).
CONCLUSION: Repeatable fluorescence lifetime values can be obtained with FLIO, but the lifetimes are affected by age, retinal thickness, vessel density, and macular location. TRANSLATIONAL RELEVANCE: Establishing repeatability of FLIO can introduce fluorescence lifetime imaging technique, which is used in basic science for analysis of excitation and emission wavelength spectrum of fixed and living cells into clinical practice.

Entities:  

Keywords:  Fluorescence Lifetime Imaging Ophthalmoscopy; fluorescence lifetime; repeatability

Year:  2019        PMID: 31114715      PMCID: PMC6506203          DOI: 10.1167/tvst.8.3.15

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  16 in total

1.  Towards metabolic mapping of the human retina.

Authors:  D Schweitzer; S Schenke; M Hammer; F Schweitzer; S Jentsch; E Birckner; W Becker; A Bergmann
Journal:  Microsc Res Tech       Date:  2007-05       Impact factor: 2.769

2.  Quantitative fundus autofluorescence in healthy eyes.

Authors:  Jonathan P Greenberg; Tobias Duncker; Russell L Woods; R Theodore Smith; Janet R Sparrow; François C Delori
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-21       Impact factor: 4.799

3.  Impact of Macular Pigment on Fundus Autofluorescence Lifetimes.

Authors:  Lydia Sauer; Dietrich Schweitzer; Lisa Ramm; Regine Augsten; Martin Hammer; Sven Peters
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

4.  Repeatability of autofluorescence lifetime imaging at the human fundus in healthy volunteers.

Authors:  Matthias Klemm; Alexander Dietzel; Jens Haueisen; Edgar Nagel; Martin Hammer; Dietrich Schweitzer
Journal:  Curr Eye Res       Date:  2013-03-26       Impact factor: 2.424

5.  Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects.

Authors:  Chantal Dysli; Gwénolé Quellec; Mathias Abegg; Marcel N Menke; Ute Wolf-Schnurrbusch; Jens Kowal; Johannes Blatz; Olivier La Schiazza; Alexander B Leichtle; Sebastian Wolf; Martin S Zinkernagel
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-03       Impact factor: 4.799

6.  In vivo measurement of time-resolved autofluorescence at the human fundus.

Authors:  Dietrich Schweitzer; Martin Hammer; Frank Schweitzer; Roswitha Anders; Torsten Doebbecke; Stefan Schenke; E R Gaillard; E R Gaillard
Journal:  J Biomed Opt       Date:  2004 Nov-Dec       Impact factor: 3.170

7.  Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease.

Authors:  Susanne Jentsch; Dietrich Schweitzer; Kai-Uwe Schmidtke; Sven Peters; Jens Dawczynski; Karl-Jürgen Bär; Martin Hammer
Journal:  Acta Ophthalmol       Date:  2014-12-07       Impact factor: 3.761

8.  Fluorescence lifetime imaging ophthalmoscopy in type 2 diabetic patients who have no signs of diabetic retinopathy.

Authors:  Dietrich Schweitzer; Lydia Deutsch; Matthias Klemm; Susanne Jentsch; Martin Hammer; Sven Peters; Jens Haueisen; Ulrich A Müller; Jens Dawczynski
Journal:  J Biomed Opt       Date:  2015-06       Impact factor: 3.170

9.  Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression.

Authors:  Chantal Dysli; Sebastian Wolf; Katja Hatz; Martin S Zinkernagel
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

10.  Autofluorescence Lifetimes in Geographic Atrophy in Patients With Age-Related Macular Degeneration.

Authors:  Chantal Dysli; Sebastian Wolf; Martin S Zinkernagel
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

View more
  7 in total

Review 1.  Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond.

Authors:  Lydia Sauer; Alexandra S Vitale; Natalie K Modersitzki; Paul S Bernstein
Journal:  Eye (Lond)       Date:  2020-12-02       Impact factor: 3.775

Review 2.  Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO).

Authors:  Niamh Wynne; Joseph Carroll; Jacque L Duncan
Journal:  Prog Retin Eye Res       Date:  2020-11-06       Impact factor: 19.704

3.  The Influence of Cataract on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO).

Authors:  Joel-Benjamin Lincke; Chantal Dysli; Damian Jaggi; Rahel Fink; Sebastian Wolf; Martin S Zinkernagel
Journal:  Transl Vis Sci Technol       Date:  2021-04-01       Impact factor: 3.283

Review 4.  The Development and Clinical Application of Innovative Optical Ophthalmic Imaging Techniques.

Authors:  Palaiologos Alexopoulos; Chisom Madu; Gadi Wollstein; Joel S Schuman
Journal:  Front Med (Lausanne)       Date:  2022-06-30

5.  Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases.

Authors:  Lukas Goerdt; Lydia Sauer; Alexandra S Vitale; Natalie K Modersitzki; Monika Fleckenstein; Paul S Bernstein
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

6.  Autofluorescence Lifetimes Measured with Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Are Affected by Age, but Not by Pigmentation or Gender.

Authors:  Lydia Sauer; Alexandra S Vitale; Cole M Milliken; Natalie K Modersitzki; J David Blount; Paul S Bernstein
Journal:  Transl Vis Sci Technol       Date:  2020-08-03       Impact factor: 3.283

7.  Influence of Lens Fluorescence on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Fundus Imaging and Strategies for Its Compensation.

Authors:  Jakob Lauritz Brauer; Rowena Schultz; Matthias Klemm; Martin Hammer
Journal:  Transl Vis Sci Technol       Date:  2020-07-09       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.